Taiwan: Claim amendment during a patent suit

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Taiwan: Claim amendment during a patent suit

A defendant in a patent lawsuit filed before the IP Court may, as a defence, challenge the validity of the patent in suit, and file a separate invalidation action against the patent with the IP Office. Although the IP Court and the IP Office often agree on patent validity in their decisions, there are sometimes disparities.

In a judgment issued in August 2015 in a patent infringement lawsuit, the Supreme Court expressed concern over the different stances adopted by the IP Court and the IP Office toward post-grant claim amendment.

The patent in suit is directed to a method for improving transmission of video data. However, in claim 1 of the patent, the preamble is followed by the expression "characterized in that" rather than "comprising the steps of" or the like. The defendant therefore argued that the patent in suit should be cancelled in view of the indefiniteness of the scope of claim 1 before the court and filed an invalidation action against the patent in suit. The patentee then filed a petition for post-grant claim amendment with the IP Office to replace "characterized in that" in claim 1 by "comprising the following steps".

According to the Examining Guidelines, the IP Office, if prepared to admit a post-grant amendment, should serve a copy of the amended claims on the invalidation petitioner for it to submit any observation thereon.

In this invalidation action, the amendment was indeed served on the invalidation petitioner, namely the defendant. The relevant documents were also entered into the IP Court's docket. In general, the IP Court would take this to mean that the IP Office is prepared to admit the amendment. However, in the infringement lawsuit, the IP Court opined that the claim amendment should not be admitted because claim 1 as amended was still indefinite. The patent was thus deemed invalid by the IP Court.

It was after the patentee filed an appeal with the Supreme Court that the IP Office formally allowed the post-grant amendment. However, the IP Office found that the claims did not involve an inventive step and cancelled the patent.

Noting the disparity between the IP Court and the IP Office regarding the admissibility of the claim amendment, the Supreme Court, in response to the appeal filed by the patentee against the judgment rendered by the IP Court, remanded the case to the IP Court for reconsideration, commenting that since the IP Office had served a copy of the claim amendment on the invalidation petitioner (the defendant), the IP Court's determination that the amendment was inadmissible was questionable.

This case sheds light on the need to review the claims of a patent and file any post-grant amendment, if necessary, when considering filing an infringement lawsuit in Taiwan based on the patent and to file the lawsuit after the amendment is granted.

Tung-Yang-Chang-Tony

Tony TY Chang


Saint Island International Patent & Law Offices7th Floor, No. 248, Section 3Nanking East RoadTaipei 105-45, Taiwan, ROCTel: +886 2 2775 1823Fax: +886 2 2731 6377siiplo@mail.saint-island.com.twwww.saint-island.com.tw

more from across site and SHARED ros bottom lb

More from across our site

Arrival of Laura Alonso, alongside a team of 11, will bring ‘significant value’ to ECIJA clients, says CEO
In the first of a two-part article, lawyers at Spruson & Ferguson and Marshall Gerstein provide an overview of China’s system for appealing against patent invalidation decisions
Lawyers and corporate leaders at INTA’s Business of M&A conference in New York discussed how cross-practice collaboration and early in-house involvement can help deals
Lily Li, partner at Morrison Foerster, shares how her litigation team helped secure victory at the ITC in a patent infringement case
Top talking points also included news of an appellate ruling concerning ‘Pisco’ and Indian drugmakers gearing up to launch generic versions of Ozempic as Novo Nordisk’s patent expires
The government’s keenly awaited view on AI and copyright has positive themes but leaves rights owners wanting, says Rebecca Newman at Addleshaw Goddard
While IP Australia’s updated manual could be favourable to computer-implemented inventions, stakeholders would like to see whether a consistent and reliable standard is followed during actual examination
UKIPO will remain a competitive option as long as efficient service continues
A future opt-out has not been ruled out, but practitioners warn that the UK could fall behind in the AI race
US patent lawyers say they are increasingly advising clients on China strategies as corporations seek to gain leverage in enforcement, licensing, and supply chain management
Gift this article